Steve Schwartz
Board Member
Mr. Schwartz brings over 30 years’ experience in corporate and business development from some of the nation’s leading health technology companies. He currently serves as Executive VP of Corporate Development at Transcarent. Prior to that Mr. Schwartz was senior vice president of Business and Corporate Development at Livongo that achieved Nasdaq’s largest digital health IPO; and then a year later helped lead the company’s $18.5 billion merger with Teladoc.
Mr. Schwartz began his career as a sales and business development leader for LabCorp, where for over a decade helped build the clinical lab company into an industry leading multi-billion-dollar success. For the next 12 years, he led corporate business development for Allscripts, where he was responsible for building the company’s massive partner ecosystem and managing strategic acquisitions while the electronic health record company grew by more than ten-fold.
Next, Mr. Schwartz was vice president of business development and strategy for 23andMe, leading a team that built strategic partnerships with Life Sciences companies, researchers, health systems, retailers, and wellness companies. After 23andMe, he joined Franklin, Tenn.-based Healthways, running the company’s emerging business segments while helping to lead the transaction that resulted in the formation of Tivity Health, unlocking over $500million in stockholder value in just under nine months.
Then in 2017, former Allscripts CEO Glen Tullman recruited Mr. Schwartz to lead business development for his new company, Livongo Health (now Teladoc Health), a digital health leader that makes it easier for people with chronic conditions such as diabetes, hypertension, and behavioral health issues to stay healthier and by doing so reducing the cost burden on employers and health plans. Today, Mr. Schwartz serves on a number of boards and part time as Executive VP of Mergers and Acquisitions for Senior Connect Acquisition Corp., a blank check company led by Chairman Richard Burke, the founder and former CEO of UnitedHealth Group.